Article

Champions Biotechnology, Inc: Tumor Xenotransplantation

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts� ("tumor xenograft") that is being developed by researchers at Champion.

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts™ (“tumor xenograft”) that is being developed by researchers at Champion.

Related Videos
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
© 2025 MJH Life Sciences

All rights reserved.